| 2GN | Name: | N-(6-(4-(2h-tetrazol-5-yl)benzyl)-3-cyano-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)-2,4-dichloro-5-(morpholinosulfonyl)benzamide | Formula: | C27 H24 Cl2 N8 O4 S2 | SMILES: | O=S(=O)(N1CCOCC1)c2cc(c(Cl)cc2Cl)C(=O)Nc3sc4c(c3C#N)CCN(C4)Cc6ccc(c5nnnn5)cc6 | InChi: | InChI=1S/C27H24Cl2N8O4S2/c28-21-12-22(29)24(43(39,40)37-7-9-41-10-8-37)11-19(21)26(38)31-27-20(13-30)18-5-6-36(15-23(18)42-27)14-16-1-3-17(4-2-16)25-32-34-35-33-25/h1-4,11-12H,5-10,14-15H2,(H,31,38)(H,32,33,34,35) | Definition date: | 2013-02-05 | Last modified: | 2014-09-05 | Release date: | 2013-07-03 | Identifier: | 2,4-dichloro-N-{3-cyano-6-[4-(2H-tetrazol-5-yl)benzyl]-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl}-5-(morpholin-4-ylsulfonyl)benzamide |
|
| 2JE | Name: | S-(2-aminoethyl) 1H-imidazole-4-carbothioate | Formula: | C6 H9 N3 O S | SMILES: | O=C(SCCN)c1ncnc1 | InChi: | InChI=1S/C6H9N3OS/c7-1-2-11-6(10)5-3-8-4-9-5/h3-4H,1-2,7H2,(H,8,9) | Definition date: | 2014-04-03 | Last modified: | 2014-09-05 | Release date: | 2014-07-23 | Identifier: | S-(2-aminoethyl) 1H-imidazole-4-carbothioate |
|
| 2JW | Name: | 1-{2-deoxy-3,5-O-[(4-nitrophenyl)(phosphono)methylidene]-beta-D-threo-pentofuranosyl}-5-methylpyrimidine-2,4(1H,3H)-dione | Formula: | C17 H18 N3 O10 P | SMILES: | [O-][N+](=O)c1ccc(cc1)C3(OCC4OC(N2C=C(C(=O)NC2=O)C)CC4O3)P(=O)(O)O | InChi: | InChI=1S/C17H18N3O10P/c1-9-7-19(16(22)18-15(9)21)14-6-12-13(29-14)8-28-17(30-12,31(25,26)27)10-2-4-11(5-3-10)20(23)24/h2-5,7,12-14H,6,8H2,1H3,(H,18,21,22)(H2,25,26,27)/t12-,13-,14-,17-/m1/s1 | Definition date: | 2013-11-12 | Last modified: | 2014-09-05 | Release date: | 2014-09-10 | Identifier: | 1-{2-deoxy-3,5-O-[(4-nitrophenyl)(phosphono)methylidene]-beta-D-threo-pentofuranosyl}-5-methylpyrimidine-2,4(1H,3H)-dione |
|
| 2K0 | Name: | [2-chloro-5-(hydroxymethyl)phenyl]{5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl}methanone | Formula: | C23 H22 Cl N5 O2 | SMILES: | Clc1ccc(cc1C(=O)c5c4cc(c2cn(nc2)C3CCNCC3)cnc4nc5)CO | InChi: | InChI=1S/C23H22ClN5O2/c24-21-2-1-14(13-30)7-19(21)22(31)20-11-27-23-18(20)8-15(9-26-23)16-10-28-29(12-16)17-3-5-25-6-4-17/h1-2,7-12,17,25,30H,3-6,13H2,(H,26,27) | Definition date: | 2014-04-07 | Last modified: | 2014-09-05 | Release date: | 2014-09-10 | Identifier: | [2-chloro-5-(hydroxymethyl)phenyl]{5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl}methanone |
|
| 2KO | Name: | 2-{2-[2-(2-{4-[(alpha-D-mannopyranosyloxy)methyl]-1H-1,2,3-triazol-1-yl}ethoxy)ethoxy]ethoxy}ethyl 2-[3,6-bis(diethylamino)-9H-xanthen-9-yl]benzoate | Formula: | C45 H61 N5 O12 | SMILES: | O=C(OCCOCCOCCOCCn1nnc(c1)COC2OC(C(O)C(O)C2O)CO)c3ccccc3C5c6ccc(N(CC)CC)cc6Oc4cc(N(CC)CC)ccc45 | InChi: | InChI=1S/C45H61N5O12/c1-5-48(6-2)31-13-15-35-37(25-31)61-38-26-32(49(7-3)8-4)14-16-36(38)40(35)33-11-9-10-12-34(33)44(55)59-24-23-58-22-21-57-20-19-56-18-17-50-27-30(46-47-50)29-60-45-43(54)42(53)41(52)39(28-51)62-45/h9-16,25-27,39-43,45,51-54H,5-8,17-24,28-29H2,1-4H3/t39-,41-,42+,43+,45+/m1/s1 | Definition date: | 2014-04-08 | Last modified: | 2014-09-05 | Release date: | 2014-08-27 | Identifier: | 2-{2-[2-(2-{4-[(alpha-D-mannopyranosyloxy)methyl]-1H-1,2,3-triazol-1-yl}ethoxy)ethoxy]ethoxy}ethyl 2-[3,6-bis(diethylamino)-9H-xanthen-9-yl]benzoate |
|
| 2KR | Name: | N-[4-(2-methoxy-3H-imidazo[4,5-b]pyridin-3-yl)phenyl]-5-methylpyridin-2-amine | Formula: | C19 H17 N5 O | SMILES: | n1cccc2nc(OC)n(c12)c4ccc(Nc3ncc(cc3)C)cc4 | InChi: | InChI=1S/C19H17N5O/c1-13-5-10-17(21-12-13)22-14-6-8-15(9-7-14)24-18-16(4-3-11-20-18)23-19(24)25-2/h3-12H,1-2H3,(H,21,22) | Definition date: | 2014-04-09 | Last modified: | 2014-09-05 | Release date: | 2014-07-23 | Identifier: | N-[4-(2-methoxy-3H-imidazo[4,5-b]pyridin-3-yl)phenyl]-5-methylpyridin-2-amine |
|
| 2L7 | Name: | 4-[(2-bromo-2-methylpropanoyl)amino]-L-phenylalanine | Formula: | C13 H17 Br N2 O3 | SMILES: | O=C(Nc1ccc(cc1)CC(C(=O)O)N)C(Br)(C)C | InChi: | InChI=1S/C13H17BrN2O3/c1-13(2,14)12(19)16-9-5-3-8(4-6-9)7-10(15)11(17)18/h3-6,10H,7,15H2,1-2H3,(H,16,19)(H,17,18)/t10-/m0/s1 | Definition date: | 2014-04-15 | Last modified: | 2014-09-05 | Release date: | 2014-07-23 | Identifier: | 4-[(2-bromo-2-methylpropanoyl)amino]-L-phenylalanine |
|
| 2LQ | Name: | 4-{[(1R,4E)-cyclooct-4-en-1-ylcarbonyl]amino}-L-phenylalanine | Formula: | C18 H24 N2 O3 | SMILES: | O=C(O)C(N)Cc1ccc(cc1)NC(=O)C2CCC=CCCC2 | InChi: | InChI=1S/C18H24N2O3/c19-16(18(22)23)12-13-8-10-15(11-9-13)20-17(21)14-6-4-2-1-3-5-7-14/h1-2,8-11,14,16H,3-7,12,19H2,(H,20,21)(H,22,23)/b2-1+/t14-,16-/m0/s1 | Definition date: | 2014-04-15 | Last modified: | 2014-09-05 | Release date: | 2014-07-23 | Identifier: | 4-{[(1R,4E)-cyclooct-4-en-1-ylcarbonyl]amino}-L-phenylalanine |
|
| 2N0 | Name: | 1-benzyl-2-ethyl-1,5,6,7-tetrahydro-4H-indol-4-one | Formula: | C17 H19 N O | SMILES: | O=C2c1cc(n(c1CCC2)Cc3ccccc3)CC | InChi: | InChI=1S/C17H19NO/c1-2-14-11-15-16(9-6-10-17(15)19)18(14)12-13-7-4-3-5-8-13/h3-5,7-8,11H,2,6,9-10,12H2,1H3 | Definition date: | 2014-04-17 | Last modified: | 2014-09-05 | Release date: | 2014-05-07 | Identifier: | 1-benzyl-2-ethyl-1,5,6,7-tetrahydro-4H-indol-4-one |
|
| 2NJ | Name: | (4S)-1-methyl-4-phenyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one | Formula: | C16 H16 N2 O | SMILES: | O=C3N(c1ccccc1NC(c2ccccc2)C3)C | InChi: | InChI=1S/C16H16N2O/c1-18-15-10-6-5-9-13(15)17-14(11-16(18)19)12-7-3-2-4-8-12/h2-10,14,17H,11H2,1H3/t14-/m0/s1 | Definition date: | 2014-04-17 | Last modified: | 2014-09-05 | Release date: | 2014-05-14 | Identifier: | (4S)-1-methyl-4-phenyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one |
|
| 2NL | Name: | 2-{3-[(4-chloropyridin-2-yl)amino]phenoxy}-N-methylacetamide | Formula: | C14 H14 Cl N3 O2 | SMILES: | O=C(NC)COc2cc(Nc1nccc(Cl)c1)ccc2 | InChi: | InChI=1S/C14H14ClN3O2/c1-16-14(19)9-20-12-4-2-3-11(8-12)18-13-7-10(15)5-6-17-13/h2-8H,9H2,1H3,(H,16,19)(H,17,18) | Definition date: | 2014-04-17 | Last modified: | 2014-09-05 | Release date: | 2014-06-25 | Identifier: | 2-{3-[(4-chloropyridin-2-yl)amino]phenoxy}-N-methylacetamide |
|
| 2NM | Name: | 3-(3-methoxyphenyl)-5-(trifluoromethyl)-1H-pyrazole | Formula: | C11 H9 F3 N2 O | SMILES: | FC(F)(F)c1cc(nn1)c2cc(OC)ccc2 | InChi: | InChI=1S/C11H9F3N2O/c1-17-8-4-2-3-7(5-8)9-6-10(16-15-9)11(12,13)14/h2-6H,1H3,(H,15,16) | Definition date: | 2014-04-18 | Last modified: | 2014-09-05 | Release date: | 2014-06-25 | Identifier: | 3-(3-methoxyphenyl)-5-(trifluoromethyl)-1H-pyrazole |
|
| GDI | Name: | (2S)-N-[(2S)-1-AZANYLIDENE-3-[4-(4-CYANOPHENYL)PHENYL]PROPAN-2-YL]PIPERIDINE-2-CARBOXAMIDE | Formula: | C22 H24 N4 O | SMILES: | O=C(NC(C=[N@H])Cc2ccc(c1ccc(C#N)cc1)cc2)C3NCCCC3 | InChi: | InChI=1S/C22H24N4O/c23-14-17-6-10-19(11-7-17)18-8-4-16(5-9-18)13-20(15-24)26-22(27)21-3-1-2-12-25-21/h4-11,15,20-21,24-25H,1-3,12-13H2,(H,26,27)/b24-15+/t20-,21-/m0/s1 | Definition date: | 2013-10-31 | Last modified: | 2014-09-05 | Release date: | 2014-03-19 | Identifier: | (2S)-N-[(2S,3E)-1-(4'-cyanobiphenyl-4-yl)-3-iminopropan-2-yl]piperidine-2-carboxamide |
|
| GFB | Name: | GUANOSINE-5'-DIPHOSPHATE-BETA-L-FUCOPYRANOSE | Formula: | C16 H25 N5 O15 P2 | SMILES: | O=C4NC(=Nc1c4ncn1C2OC(C(O)C2O)COP(=O)(OP(=O)(OC3OC(C(O)C(O)C3O)C)O)O)N | InChi: | InChI=1S/C16H25N5O15P2/c1-4-7(22)9(24)11(26)15(33-4)35-38(30,31)36-37(28,29)32-2-5-8(23)10(25)14(34-5)21-3-18-6-12(21)19-16(17)20-13(6)27/h3-5,7-11,14-15,22-26H,2H2,1H3,(H,28,29)(H,30,31)(H3,17,19,20,27)/t4-,5+,7+,8+,9+,10+,11-,14+,15+/m0/s1 | Definition date: | 2011-08-17 | Last modified: | 2014-09-05 | Identifier: | [(2R,3S,4R,5R)-5-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl dihydrogen diphosphate (non-preferred name) |
|
| GHE | Name: | (2R)-1-[6-[(2R)-2-carboxypyrrolidin-1-yl]-6-oxidanylidene-hexanoyl]pyrrolidine-2-carboxylic acid | Formula: | C16 H24 N2 O6 | SMILES: | O=C(N1C(C(=O)O)CCC1)CCCCC(=O)N2C(C(=O)O)CCC2 | InChi: | InChI=1S/C16H24N2O6/c19-13(17-9-3-5-11(17)15(21)22)7-1-2-8-14(20)18-10-4-6-12(18)16(23)24/h11-12H,1-10H2,(H,21,22)(H,23,24)/t11-,12-/m1/s1 | Definition date: | 2012-05-29 | Last modified: | 2014-09-05 | Release date: | 2013-06-19 | Identifier: | (2R,2'R)-1,1'-(1,6-dioxohexane-1,6-diyl)dipyrrolidine-2-carboxylic acid (non-preferred name) |
|
| GMF | Name: | 2-[[3-(3-methoxyphenyl)phenyl]-(4-pyridyl)methyl]guanidine | Formula: | C20 H20 N4 O | SMILES: | O(c1cccc(c1)c2cccc(c2)C(NC(=[N@H])N)c3ccncc3)C | InChi: | InChI=1S/C20H20N4O/c1-25-18-7-3-5-16(13-18)15-4-2-6-17(12-15)19(24-20(21)22)14-8-10-23-11-9-14/h2-13,19H,1H3,(H4,21,22,24)/t19-/m1/s1 | Definition date: | 2012-07-04 | Last modified: | 2014-09-05 | Release date: | 2013-07-24 | Identifier: | 1-[(S)-(3'-methoxybiphenyl-3-yl)(pyridin-4-yl)methyl]guanidine |
|
| GMK | Name: | (3-Deoxy-3-(3-methoxy-benzamido)-b-D-galactopyranosyl)-(3-deoxy-3-(3-methoxy-benzamido)-2-O-sulfo-b-D-galactopyranosyl)-sulfide | Formula: | C28 H36 N2 O15 S2 | SMILES: | O=S(=O)(O)OC4C(NC(=O)c1cccc(OC)c1)C(O)C(OC4SC3OC(CO)C(O)C(NC(=O)c2cccc(OC)c2)C3O)CO | InChi: | InChI=1S/C28H36N2O15S2/c1-41-15-7-3-5-13(9-15)25(36)29-19-21(33)17(11-31)43-27(23(19)35)46-28-24(45-47(38,39)40)20(22(34)18(12-32)44-28)30-26(37)14-6-4-8-16(10-14)42-2/h3-10,17-24,27-28,31-35H,11-12H2,1-2H3,(H,29,36)(H,30,37)(H,38,39,40)/t17-,18-,19+,20+,21+,22+,23-,24-,27+,28+/m1/s1 | Definition date: | 2013-05-03 | Last modified: | 2014-09-05 | Release date: | 2014-05-21 | Identifier: | 3-deoxy-3-[(3-methoxybenzoyl)amino]-beta-D-galactopyranosyl 3-deoxy-3-[(3-methoxybenzoyl)amino]-2-O-sulfo-1-thio-beta-D-galactopyranoside |
|
| GMV | Name: | GUANOSINE-5'-PHOSPHOVANADATE | Formula: | C10 H17 N5 O12 P V | SMILES: | O=P(O[V](O)(O)(O)O)(O)OCC3OC(n2cnc1c2N=C(N)NC1=O)C(O)C3O | InChi: | InChI=1S/C10H14N5O8P.4H2O.V/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(23-9)1-22-24(19,20)21 | Definition date: | 2013-06-04 | Last modified: | 2014-09-05 | Release date: | 2013-07-17 | Identifier: | vanadium(5+) hydroxide 5'-O-[(R)-hydroxyphosphinato]guanosine (1:4:1) |
|
| 5MI | Name: | 5-METHYL INDOLE | Formula: | C9 H9 N | SMILES: | c1c(ccc2c1ccn2)C | InChi: | InChI=1S/C9H9N/c1-7-2-3-9-8(6-7)4-5-10-9/h2-6,10H,1H3 | Definition date: | 2012-07-23 | Last modified: | 2014-09-05 | Release date: | 2013-02-01 | Identifier: | 5-methyl-1H-indole |
|
| 5PS | Name: | (R)-N-(3-(1H-indol-3-yl)-1-oxo-1-(pyridin-4-ylamino)propan-2-yl)-3,3'-difluoro-(1,1'-biphenyl)-4-carboxamide | Formula: | C29 H22 F2 N4 O2 | SMILES: | Fc1cccc(c1)c2ccc(c(F)c2)C(=O)NC(C(=O)Nc3ccncc3)Cc5c4ccccc4nc5 | InChi: | InChI=1S/C29H22F2N4O2/c30-21-5-3-4-18(14-21)19-8-9-24(25(31)15-19)28(36)35-27(29(37)34-22-10-12-32-13-11-22)16-20-17-33-26-7-2-1-6-23(20)26/h1-15,17,27,33H,16H2,(H,35,36)(H,32,34,37)/t27-/m1/s1 | Definition date: | 2013-07-16 | Last modified: | 2014-09-05 | Release date: | 2014-01-22 | Identifier: | 3,3'-difluoro-N-[(2R)-3-(1H-indol-3-yl)-1-oxo-1-(pyridin-4-ylamino)propan-2-yl]biphenyl-4-carboxamide |
|
| GSY | Name: | 7-(2-HYDROXYETHYL)-8-MERCAPTOGUANINE | Formula: | C7 H9 N5 O2 S | SMILES: | O=C1c2c(N=C(N1)N)nc(S)n2CCO | InChi: | InChI=1S/C7H9N5O2S/c8-6-9-4-3(5(14)11-6)12(1-2-13)7(15)10-4/h13H,1-2H2,(H4,8,9,10,11,14,15) | Definition date: | 2011-12-22 | Last modified: | 2014-09-05 | Release date: | 2013-01-11 | Identifier: | 2-amino-7-(2-hydroxyethyl)-8-sulfanyl-1,7-dihydro-6H-purin-6-one |
|
| H0Y | Name: | 6-[(8E)-8-(1,3-benzothiazol-2-ylhydrazinylidene)-6,7-dihydro-5H-naphthalen-2-yl]pyridine-2-carboxylic acid | Formula: | C23 H18 N4 O2 S | SMILES: | O=C(O)c1nc(ccc1)c2ccc5c(c2)/C(=N/Nc3nc4ccccc4s3)CCC5 | InChi: | InChI=1S/C23H18N4O2S/c28-22(29)20-9-4-7-17(24-20)15-12-11-14-5-3-8-18(16(14)13-15)26-27-23-25-19-6-1-2-10-21(19)30-23/h1-2,4,6-7,9-13H,3,5,8H2,(H,25,27)(H,28,29)/b26-18+ | Definition date: | 2013-02-04 | Last modified: | 2014-09-05 | Release date: | 2013-04-24 | Identifier: | 6-{(8E)-8-[2-(1,3-benzothiazol-2-yl)hydrazinylidene]-5,6,7,8-tetrahydronaphthalen-2-yl}pyridine-2-carboxylic acid |
|
| H1I | Name: | N-(3-(5-(1-(2-(benzo[d]thiazol-2-yl)hydrazono)ethyl)furan-2-yl)phenylsulfonyl)-6-phenylhexanamide | Formula: | C31 H30 N4 O4 S2 | SMILES: | O=C(NS(=O)(=O)c1cccc(c1)c2oc(cc2)/C(=N/Nc3nc4ccccc4s3)C)CCCCCc5ccccc5 | InChi: | InChI=1S/C31H30N4O4S2/c1-22(33-34-31-32-26-16-8-9-17-29(26)40-31)27-19-20-28(39-27)24-14-10-15-25(21-24)41(37,38)35-30(36)18-7-3-6-13-23-11-4-2-5-12-23/h2,4-5,8-12,14-17,19-21H,3,6-7,13,18H2,1H3,(H,32,34)(H,35,36)/b33-22+ | Definition date: | 2013-01-22 | Last modified: | 2014-09-05 | Release date: | 2013-04-24 | Identifier: | N-{[3-(5-{(1E)-1-[2-(1,3-benzothiazol-2-yl)hydrazinylidene]ethyl}furan-2-yl)phenyl]sulfonyl}-6-phenylhexanamide |
|
| 4AU | Name: | 1H-benzimidazol-2-yl(1H-pyrrol-2-yl)methanone | Formula: | C12 H9 N3 O | SMILES: | O=C(c2nc1ccccc1n2)c3cccn3 | InChi: | InChI=1S/C12H9N3O/c16-11(10-6-3-7-13-10)12-14-8-4-1-2-5-9(8)15-12/h1-7,13H,(H,14,15) | Definition date: | 2012-05-15 | Last modified: | 2014-09-05 | Release date: | 2013-02-01 | Identifier: | 1H-benzimidazol-2-yl(1H-pyrrol-2-yl)methanone |
|
| 4D2 | Name: | 5-[(2S)-4-methyl-2-[(pyridin-3-ylcarbonylamino)methyl]pentyl]-1,3-benzodioxole-4-carboxylic acid | Formula: | C21 H24 N2 O5 | SMILES: | O=C(O)c1c(ccc2OCOc12)CC(CC(C)C)CNC(=O)c3cccnc3 | InChi: | InChI=1S/C21H24N2O5/c1-13(2)8-14(10-23-20(24)16-4-3-7-22-11-16)9-15-5-6-17-19(28-12-27-17)18(15)21(25)26/h3-7,11,13-14H,8-10,12H2,1-2H3,(H,23,24)(H,25,26)/t14-/m0/s1 | Definition date: | 2013-12-22 | Last modified: | 2014-09-05 | Release date: | 2014-01-08 | Identifier: | 5-[(2S)-4-methyl-2-{[(pyridin-3-ylcarbonyl)amino]methyl}pentyl]-1,3-benzodioxole-4-carboxylic acid |
|